Cita APA (7a ed.)

Boutin, J., Rosier, J., Cappellen, D., Prat, F., Toutain, J., Pennamen, P., . . . Bedel, A. (2021). CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. Nature Portfolio.

Cita Chicago Style (17a ed.)

Boutin, J., et al. CRISPR-Cas9 Globin Editing Can Induce Megabase-scale Copy-neutral Losses of Heterozygosity in Hematopoietic Cells. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Boutin, J., et al. CRISPR-Cas9 Globin Editing Can Induce Megabase-scale Copy-neutral Losses of Heterozygosity in Hematopoietic Cells. Nature Portfolio, 2021.